AMSF vs GSK · P/E 18, rev $172.1M vs P/E 13, $103.31B cap
AMERISAFE Inc (AMSF) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
AMERISAFE Inc (AMSF) is a insurance - specialty company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AMSF revenue for 2026-06-30 was $172.1M. Net income was $22.7M. AMSF currently screens at market cap $841.3M and trailing P/E 17.8.
GSK does not have a complete income-statement cache yet.
AMSF currently screens at market cap $841.3M and trailing P/E 17.8. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AMSF and GSK stock pages for the full models.
Not investment advice.